The chairman of Novartis AG (ADR)(NYSE:NVS), Joerg Reinhardt, has said that the pharmaceutical giant has reconsidered selling its 33% stake in Roche, worth approximately $14 billion, after a review was conducted.
To divest company-specific risks, investors can consider ETFs like the BLDRS Europe Select ADR ETF (ADRU), which has 6.7% of its total assets in Novartis AG ADRs (NVS). ADRU also holds 3.3% in Sanofi ADRs (SNY), 2.9% in GlaxoSmithKline ADRs ...
Ct Mason increased its stake in Novartis Ag Adr (NVS) by 13.45% based on its latest 2017Q2 regulatory filing with the SEC. Ct Mason bought 5,500 shares as the company's stock rose 4.17% with the market.
Among 5 analysts covering Selective Insurance (NASDAQ:SIGI), 0 have Buy rating, 0 Sell and 5 Hold. Therefore 0 are positive. Selective Insurance had 12 analyst reports since July 31, 2015 according to SRatingsIntel.